MedTrace Logo

DSE vs Invasive FFR vs CT-FFR

NCT03988881 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-06-18

No results posted yet for this study

Summary

Data are limited regarding the optimal treatment of the non-culprit lesions (NCL) after myocardial infarction (MI). The NON-CULPRIT study is a prospective cohort study with a primary aim to compare invasive fractional flow reserve (FFR) and dobutamine stress echocardiography (DSE) for the evaluation and treatment of NCL in patients with MI.

As a secondary aim the investigators will assess the diagnostic performance of CT derived FFR as compared to invasive FFR and DSE measurements.

Conditions

  • Fractional Flow Reserve

Interventions

PROCEDURE

Revascularization

PCI or CABG

Sponsors & Collaborators

  • Bajcsy-Zsilinszky Hospital

    collaborator OTHER

  • Semmelweis University Heart and Vascular Center

    lead OTHER

Principal Investigators

  • Peter Andrassy, MD PhD · Bajcsy-Zsilinszky Hospital

  • Pal Maurovich-Horvat, MD PhD MPH · Heart and Vascular Center, Semmelweis University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-30
Primary Completion
2019-07-30
Completion
2021-07-30

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03988881 on ClinicalTrials.gov